Phase II study of pre-operative treatment with external radiotherapy plus panitumumab in operable locally advanced rectal cancer (favourable and intermediate prognostic group) (RaP Study/STAR-03)
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Panitumumab (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms RaP/STAR-03
- 15 Feb 2018 Status changed from recruiting to completed.
- 02 Jun 2015 According to an abstract presented at the 51st Annual Meeting of the American Society of Clinical Oncology, 67 patients has been enrolled till Jan 2015.
- 02 Jun 2015 Interim results (n=55) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.